Identification of Coinfections by Viral and Bacterial Pathogens in COVID-19 Hospitalized Patients in Peru: Molecular Diagnosis and Clinical Characteristics
The impact of respiratory coinfections in COVID-19 is still not well understood despite the growing evidence that consider coinfections greater than expected. A total of 295 patients older than 18 years of age, hospitalized with a confirmed diagnosis of moderate/severe pneumonia due to SARS-CoV-2 in...
Guardado en:
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6001f795b10149c4a9eecb445d48cdd3 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:6001f795b10149c4a9eecb445d48cdd3 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:6001f795b10149c4a9eecb445d48cdd32021-11-25T16:23:32ZIdentification of Coinfections by Viral and Bacterial Pathogens in COVID-19 Hospitalized Patients in Peru: Molecular Diagnosis and Clinical Characteristics10.3390/antibiotics101113582079-6382https://doaj.org/article/6001f795b10149c4a9eecb445d48cdd32021-11-01T00:00:00Zhttps://www.mdpi.com/2079-6382/10/11/1358https://doaj.org/toc/2079-6382The impact of respiratory coinfections in COVID-19 is still not well understood despite the growing evidence that consider coinfections greater than expected. A total of 295 patients older than 18 years of age, hospitalized with a confirmed diagnosis of moderate/severe pneumonia due to SARS-CoV-2 infection (according to definitions established by the Ministry of Health of Peru) were enrolled during the study period. A coinfection with one or more respiratory pathogens was detected in 154 (52.2%) patients at hospital admission. The most common coinfections were <i>Mycoplasma pneumoniae</i> (28.1%), <i>Chlamydia pneumoniae</i> (8.8%) and with both bacteria (11.5%); followed by Adenovirus (1.7%), <i>Mycoplasma pneumoniae</i>/Adenovirus (0.7%), <i>Chlamydia pneumoniae</i>/Adenovirus (0.7%), RSV-B/<i>Chlamydia pneumoniae</i> (0.3%) and <i>Mycoplasma pneumoniae</i>/<i>Chlamydia pneumoniae</i>/Adenovirus (0.3%). Expectoration was less frequent in coinfected individuals compared to non-coinfected (5.8% vs. 12.8%). Sepsis was more frequent among coinfected patients than non-coinfected individuals (33.1% vs. 20.6%) and 41% of the patients who received macrolides empirically were PCR-positive for <i>Mycoplasma pneumoniae</i> and <i>Chlamydia pneumoniae</i>.Giancarlo Pérez-LazoWilmer Silva-CasoJuana del Valle-MendozaAdriana Morales-MorenoJosé Ballena-LópezFernando Soto-FebresJohanna Martins-LunaHugo Carrillo-NgLuís J. del ValleSungmin KymMiguel Angel Aguilar-LuisIssac Peña-TuestaCarmen Tinco-ValdezLuis Ricardo IllescasMDPI AGarticlecoinfectionsCOVID-19antibioticsTherapeutics. PharmacologyRM1-950ENAntibiotics, Vol 10, Iss 1358, p 1358 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
coinfections COVID-19 antibiotics Therapeutics. Pharmacology RM1-950 |
spellingShingle |
coinfections COVID-19 antibiotics Therapeutics. Pharmacology RM1-950 Giancarlo Pérez-Lazo Wilmer Silva-Caso Juana del Valle-Mendoza Adriana Morales-Moreno José Ballena-López Fernando Soto-Febres Johanna Martins-Luna Hugo Carrillo-Ng Luís J. del Valle Sungmin Kym Miguel Angel Aguilar-Luis Issac Peña-Tuesta Carmen Tinco-Valdez Luis Ricardo Illescas Identification of Coinfections by Viral and Bacterial Pathogens in COVID-19 Hospitalized Patients in Peru: Molecular Diagnosis and Clinical Characteristics |
description |
The impact of respiratory coinfections in COVID-19 is still not well understood despite the growing evidence that consider coinfections greater than expected. A total of 295 patients older than 18 years of age, hospitalized with a confirmed diagnosis of moderate/severe pneumonia due to SARS-CoV-2 infection (according to definitions established by the Ministry of Health of Peru) were enrolled during the study period. A coinfection with one or more respiratory pathogens was detected in 154 (52.2%) patients at hospital admission. The most common coinfections were <i>Mycoplasma pneumoniae</i> (28.1%), <i>Chlamydia pneumoniae</i> (8.8%) and with both bacteria (11.5%); followed by Adenovirus (1.7%), <i>Mycoplasma pneumoniae</i>/Adenovirus (0.7%), <i>Chlamydia pneumoniae</i>/Adenovirus (0.7%), RSV-B/<i>Chlamydia pneumoniae</i> (0.3%) and <i>Mycoplasma pneumoniae</i>/<i>Chlamydia pneumoniae</i>/Adenovirus (0.3%). Expectoration was less frequent in coinfected individuals compared to non-coinfected (5.8% vs. 12.8%). Sepsis was more frequent among coinfected patients than non-coinfected individuals (33.1% vs. 20.6%) and 41% of the patients who received macrolides empirically were PCR-positive for <i>Mycoplasma pneumoniae</i> and <i>Chlamydia pneumoniae</i>. |
format |
article |
author |
Giancarlo Pérez-Lazo Wilmer Silva-Caso Juana del Valle-Mendoza Adriana Morales-Moreno José Ballena-López Fernando Soto-Febres Johanna Martins-Luna Hugo Carrillo-Ng Luís J. del Valle Sungmin Kym Miguel Angel Aguilar-Luis Issac Peña-Tuesta Carmen Tinco-Valdez Luis Ricardo Illescas |
author_facet |
Giancarlo Pérez-Lazo Wilmer Silva-Caso Juana del Valle-Mendoza Adriana Morales-Moreno José Ballena-López Fernando Soto-Febres Johanna Martins-Luna Hugo Carrillo-Ng Luís J. del Valle Sungmin Kym Miguel Angel Aguilar-Luis Issac Peña-Tuesta Carmen Tinco-Valdez Luis Ricardo Illescas |
author_sort |
Giancarlo Pérez-Lazo |
title |
Identification of Coinfections by Viral and Bacterial Pathogens in COVID-19 Hospitalized Patients in Peru: Molecular Diagnosis and Clinical Characteristics |
title_short |
Identification of Coinfections by Viral and Bacterial Pathogens in COVID-19 Hospitalized Patients in Peru: Molecular Diagnosis and Clinical Characteristics |
title_full |
Identification of Coinfections by Viral and Bacterial Pathogens in COVID-19 Hospitalized Patients in Peru: Molecular Diagnosis and Clinical Characteristics |
title_fullStr |
Identification of Coinfections by Viral and Bacterial Pathogens in COVID-19 Hospitalized Patients in Peru: Molecular Diagnosis and Clinical Characteristics |
title_full_unstemmed |
Identification of Coinfections by Viral and Bacterial Pathogens in COVID-19 Hospitalized Patients in Peru: Molecular Diagnosis and Clinical Characteristics |
title_sort |
identification of coinfections by viral and bacterial pathogens in covid-19 hospitalized patients in peru: molecular diagnosis and clinical characteristics |
publisher |
MDPI AG |
publishDate |
2021 |
url |
https://doaj.org/article/6001f795b10149c4a9eecb445d48cdd3 |
work_keys_str_mv |
AT giancarloperezlazo identificationofcoinfectionsbyviralandbacterialpathogensincovid19hospitalizedpatientsinperumoleculardiagnosisandclinicalcharacteristics AT wilmersilvacaso identificationofcoinfectionsbyviralandbacterialpathogensincovid19hospitalizedpatientsinperumoleculardiagnosisandclinicalcharacteristics AT juanadelvallemendoza identificationofcoinfectionsbyviralandbacterialpathogensincovid19hospitalizedpatientsinperumoleculardiagnosisandclinicalcharacteristics AT adrianamoralesmoreno identificationofcoinfectionsbyviralandbacterialpathogensincovid19hospitalizedpatientsinperumoleculardiagnosisandclinicalcharacteristics AT joseballenalopez identificationofcoinfectionsbyviralandbacterialpathogensincovid19hospitalizedpatientsinperumoleculardiagnosisandclinicalcharacteristics AT fernandosotofebres identificationofcoinfectionsbyviralandbacterialpathogensincovid19hospitalizedpatientsinperumoleculardiagnosisandclinicalcharacteristics AT johannamartinsluna identificationofcoinfectionsbyviralandbacterialpathogensincovid19hospitalizedpatientsinperumoleculardiagnosisandclinicalcharacteristics AT hugocarrillong identificationofcoinfectionsbyviralandbacterialpathogensincovid19hospitalizedpatientsinperumoleculardiagnosisandclinicalcharacteristics AT luisjdelvalle identificationofcoinfectionsbyviralandbacterialpathogensincovid19hospitalizedpatientsinperumoleculardiagnosisandclinicalcharacteristics AT sungminkym identificationofcoinfectionsbyviralandbacterialpathogensincovid19hospitalizedpatientsinperumoleculardiagnosisandclinicalcharacteristics AT miguelangelaguilarluis identificationofcoinfectionsbyviralandbacterialpathogensincovid19hospitalizedpatientsinperumoleculardiagnosisandclinicalcharacteristics AT issacpenatuesta identificationofcoinfectionsbyviralandbacterialpathogensincovid19hospitalizedpatientsinperumoleculardiagnosisandclinicalcharacteristics AT carmentincovaldez identificationofcoinfectionsbyviralandbacterialpathogensincovid19hospitalizedpatientsinperumoleculardiagnosisandclinicalcharacteristics AT luisricardoillescas identificationofcoinfectionsbyviralandbacterialpathogensincovid19hospitalizedpatientsinperumoleculardiagnosisandclinicalcharacteristics |
_version_ |
1718413201587044352 |